Oruka Therapeutics Inc. (NASDAQ: ORKA) announced that its experimental psoriasis treatment ORKA-001 achieved complete skin clearance in 63.5% of patients ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA